Anti-AMPK alpha 2 (phospho S491) antibody [EPR3052]
- RabMAb
- Recombinant
- What is this?
5
(1 Review)
|
(14 Publications)
Rabbit Recombinant Monoclonal AMPK alpha 2 phospho S491 antibody. Suitable for WB and reacts with Human samples. Cited in 14 publications.
View Alternative Names
AMPK, AMPK2, PRKAA2, 5'-AMP-activated protein kinase catalytic subunit alpha-2, AMPK subunit alpha-2, Acetyl-CoA carboxylase kinase, Hydroxymethylglutaryl-CoA reductase kinase, ACACA kinase, HMGCR kinase
- WB
Unknown
Western blot - Anti-AMPK alpha 2 (phospho S491) antibody [EPR3052] (AB109402)
All lanes:
Western blot - Anti-AMPK alpha 2 (phospho S491) antibody [EPR3052] (ab109402) at 1/1000 dilution
Lane 1:
HEK-293 (Human embryonic kidney epithelial cell) whole cell lysate
Lane 2:
HEK-293 (Human embryonic kidney epithelial cell) whole cell lysate, then the membrane treated with Lambda Phosphatase for 1 hour
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 62 kDa
false
Related conjugates and formulations (1)
-
Anti-AMPK alpha 2 (phospho S491) antibody [EPR3052] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (14)
Recent publications for all applications. Explore the full list and refine your search
Cancer medicine 14:e71013 PubMed40583724
2025
Applications
Unspecified application
Species
Unspecified reactive species
European journal of medical research 30:359 PubMed40319296
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell chemical biology 30:1585-1600.e6 PubMed37890479
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular neurobiology 43:2325-2335 PubMed36441266
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 13:870699 PubMed35592411
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in microbiology 13:861734 PubMed35359726
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 25: PubMed35169857
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 12:716884 PubMed34867324
2021
Applications
Unspecified application
Species
Unspecified reactive species
The Prostate 81:1135-1148 PubMed34411320
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 12:648688 PubMed34054527
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com